Physiotherapy for Infants With Bronchiolities

September 24, 2021 updated by: Lund University

Physiotherapy Including Frequent Changes of Body Position and Stimulation to Physical Activity for Infants With Bronchiolitis and Other Acute Respiratory Infections - a Randomized Controlled Trial

Children who are in a hospital with respiratory distress often have difficulty breathing, have thick mucus, and may find it hard to eat normally. Sometimes physical therapy is used to treat these children, but it is not entirely known which methods help the children's condition. The aim of this study is to evaluate the most common physiotherapy treatment method that is currently in use in Sweden for infants who are hospitalized with a lower respiratory infection.

Study Overview

Detailed Description

All children under 2 years of age who are admitted to the hospital for a respiratory infection and who have previously been essentially healthy are asked to participate. The infants will be randomized to 3 groups, 1 control group and 2 intervention groups. The infants in the control group will receive the standard care at the clinic. In one intervention group the parents will receive instructions how to vary their child body position regularly, and in the other intervention group the child will receive physiotherapy regularly and the parents will carry out some treatment. Further actions in the form of inhalations or stimulation of deep breathing, will be used when needed. The children will be observed following a structured observational protocol regularly throughout the hospital stay.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 2 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Infants hospitalized because of respiratory infections such as bronchiolitis, pneumonia or other airway obstructions.
  • Age 0-24 months
  • Born in gestation week 35 or later.
  • Guardians understand written Swedish, English, Arabic or Persian

Exclusion Criteria:

  • Previous cardiac or respiratory disease
  • hospitalized more than 24 hours on this occasion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
The infants will receive the standard care at the ward.
Experimental: Non-individualized
The parents will be guided manually by the nursing staff and receive written information about how to change body positions of their child regularly throughout the hospital stay.
Comparing two experimental interventions with standard care
Experimental: Individualized
The infant will receive frequent changes of body positions, stimulation to physical activity, and stimulation to deep breathing while bouncing on a large ball in the arms of an adult. Additional light chest compressions and inhalations may be given. A physiotherapist will perform the intervention at least once daily, and the parents will be manually guided and receive written information about how to change body positions of their child regularly in a similar way throughout the hospital stay.
Comparing two experimental interventions with standard care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to improvement
Time Frame: Baseline, after 20 minutes, and every third hour up to discharge from hospital, no more than two weeks
First improvement regarding any of the following: Wang respiratory score, use of supplemented oxygen, use of supplemented high air flow, use of tube feeding, hospital stay
Baseline, after 20 minutes, and every third hour up to discharge from hospital, no more than two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxygen saturation
Time Frame: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Change in percutanous oxygen saturation measured by probe on the foot
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
respiratory rate
Time Frame: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Change in manually counted RR during one minute
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Heart rate
Time Frame: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Change in pulse oximeter
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
General condition, parents' assessment
Time Frame: Baseline and every third hour up to discharge from hospital, no more than two weeks
Time to the first reduction in Numeric Rating Scale 0-10, (0 the best, 10 the worst)
Baseline and every third hour up to discharge from hospital, no more than two weeks
Lung complications
Time Frame: At discharge from the ward, no more than two weeks
Referral to an intensive care unit
At discharge from the ward, no more than two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2018

Primary Completion (Anticipated)

May 31, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

October 13, 2017

First Submitted That Met QC Criteria

June 29, 2018

First Posted (Actual)

July 2, 2018

Study Record Updates

Last Update Posted (Actual)

September 30, 2021

Last Update Submitted That Met QC Criteria

September 24, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2017/190

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe